[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100219166":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":21,"centralContacts":21,"locations":23,"responsibleParty":35,"collaborators":21,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":21,"eligibilityCriteria":43,"healthyVolunteers":40,"sex":44,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":21,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":63,"whyStopped":21,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Campania Luigi Vanvitelli","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Resveratrol nasal spray","ACTIVE_COMPARATOR","2 sprays per nostril 3 times a day for a period of two months",[13],"Drug: Resveratrol nasal spray",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo","PLACEBO_COMPARATOR",[13],[19],{"type":20,"name":9,"description":21,"armGroupLabels":22,"otherNames":21},"DRUG",null,[15,9],[24],{"facility":25,"status":21,"city":26,"state":27,"zip":21,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":21},"Second University of Naples","Naples","Italy","IT",{"type":30,"coordinates":31},"Point",[32,33],14.26811,40.85216,{"lat":33,"lon":32},{"type":36,"investigatorFullName":37,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"PRINCIPAL_INVESTIGATOR","Prof. Michele Miraglia del Giudice","100219166","phase-3-evaluation-of-the-beneficial-effects-of-a-nasal-spray-of-resveratrol-in-children-with-seasonal-allergic-rhinitis-100219166",false,"NCT02130440","Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis","Inclusion Criteria:\n\n* Children of both sexes, ranging in age from 4 to 17 years\n* History of seasonal allergic rhinitis, mild, moderate or severe, defined according to the ARIA guidelines in 2010, documented by recurrent episodes in the previous year and confirmed by a positive skin test results\n* Written informed consent from at least one parent or a legal representative\n\nExclusion Criteria:\n\n* Lack of informed consent in writing by at least one parent or a legal representative\n* Concomitant disorders, such as infection of the upper (sinusitis, etc..) or lower respiratory tract, nasal surgery in the last year, abnormalities of the respiratory tract, immune diseases\n* Use of antihistamines, nasal or systemic corticosteroids, leukotriene modifiers, cromolyn sodium, in the last six weeks","ALL","4 Years","17 Years",{"count":48,"type":49},100,"ACTUAL","INTERVENTIONAL",[52],"PHASE3","The aim of this study is to evaluate whether treatment with a nasal spray based on resveratrol has some benefit in patients with seasonal allergic rhinitis, mild, moderate, or severe.",[55],"Seasonal Allergic Rhinitis",[57,58,59,60,61,62],"nasal obstruction","sneezing","itching","rhinorrhea","respiratory infections","wheezing","COMPLETED","2014-05-01",{"date":66,"type":67},"2014-05-05","ESTIMATED",{"date":69,"type":21},"2012-11",{"date":71,"type":49},"2014-04",{"name":5,"class":6},1]